Keywords: fda, clears, trovafloxacin, ultra-broad, indications, pfizer, once-daily

FDA Clears Trovafloxacin With Ultra-Broad Indications

Article | 24 December 1997

Pfizer's once-daily quinolone antibiotic Trovan (trovafloxacin) has beenapproved for marketing in the USA with the broadest number of indications ever ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pfizer

Go to company listing

Related Drugs

Nystatin

Grepafloxacin

Raxar

Go to drug listing